Cargando…

PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases

BACKGROUND: Genetic variants of IFNL4 and PDCD1 genes have been shown to influence the spontaneous clearance of hepatitis C virus (HCV) infection. We investigated the IFNL4 rs12979860 and the PDCD1 polymorphisms in 734 HCV‐positive patients, including 461 cases with liver disease of varying severity...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Re, Valli, Tornesello, Maria Lina, De Zorzi, Mariangela, Caggiari, Laura, Pezzuto, Francesca, Leone, Patrizia, Racanelli, Vito, Lauletta, Gianfranco, Zanussi, Stefania, Repetto, Ombretta, Gragnani, Laura, Rossi, Francesca Maria, Dolcetti, Riccardo, Zignego, Anna Linda, Buonaguro, Franco M., Steffan, Agostino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Genetics and Rare Liver Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839592/ https://www.ncbi.nlm.nih.gov/pubmed/32937024 http://dx.doi.org/10.1111/liv.14667

Ejemplares similares

Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma
por: De Re, Valli, et al.
Publicado: (2019)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients
por: Corona, Giuseppe, et al.
Publicado: (2018)

Molecular Signature in HCV-Positive Lymphomas
por: De Re, Valli, et al.
Publicado: (2012)

Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options
por: Re, Valli De, et al.
Publicado: (2020)

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
por: De Re, Valli, et al.
Publicado: (2016)

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
por: De Re, Valli, et al.
Publicado: (2015)

Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
por: De Re, Valli, et al.
Publicado: (2015)

Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer
por: De Re, Valli, et al.
Publicado: (2017)

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
por: De Re, Valli, et al.
Publicado: (2014)

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2018)

Family’s History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form
por: Caggiari, Laura, et al.
Publicado: (2020)

Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2019)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2017)

Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
por: Repetto, Ombretta, et al.
Publicado: (2022)

Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

Non-Classical HLA Class 1b and Hepatocellular Carcinoma
por: De Re, Valli, et al.
Publicado: (2023)

Antibody V(h) Repertoire Differences between Resolving and Chronically Evolving Hepatitis C Virus Infections
por: Racanelli, Vito, et al.
Publicado: (2011)

Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis
por: Haisma, Sjoukje‐Marije, et al.
Publicado: (2021)

The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer
por: Tornesello, Maria Lina, et al.
Publicado: (2020)

Sebelipase alfa for lysosomal acid lipase deficiency: 5‐year treatment experience from a phase 2 open‐label extension study
por: Malinová, Vĕra, et al.
Publicado: (2020)

Choledochal malformations in adults in the Netherlands: Results from a nationwide retrospective cohort study
por: de Kleine, Ruben H., et al.
Publicado: (2020)

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2020)

Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population
por: Chen, Haizhen, et al.
Publicado: (2020)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection
por: Schaapman, Jelte J., et al.
Publicado: (2020)

Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease
por: Paternostro, Rafael, et al.
Publicado: (2020)

Prolonged exposure to welding fumes as a novel cause of systemic iron overload
por: Mariani, Raffaella, et al.
Publicado: (2021)

Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism)
por: Sivunen, Johanna, et al.
Publicado: (2022)

A minority of somatically mutated genes in pre‐existing fatty liver disease have prognostic importance in the development of NAFLD
por: Mann, Jake P., et al.
Publicado: (2022)

Clinical characterization of NTCP deficiency in paediatric patients : A case‐control study based on SLC10A1 genotyping analysis
por: Deng, Li‐Jing, et al.
Publicado: (2021)

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
por: Ventura, Paolo, et al.
Publicado: (2021)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer
por: Garziera, Marica, et al.
Publicado: (2013)

Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2021)

Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2016)

Exercise therapy in primary biliary cirrhosis: the importance of moving while sitting on a surgical waiting list—a case study
por: Hallsworth, Kate, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i8eqtt9jhhf3aipo3brt9dllli